Transcriptomics Market to Grow with a CAGR of 5.33% through 2030
Increasing
demand for precision medicine is expected to drive the growth of global
transcriptomics in the forecast period, 2026-2030.
According
to TechSci Research report, “Transcriptomics Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, the Global
Transcriptomics Market stood at USD 7.53 billion in 2024 and is
anticipated to grow with a CAGR of 5.33% in the forecast period through 2030.
This can be ascribed to the increasing demand for personalized medicine for the
treatment of specific diseases in people, worldwide. Additionally, rising
development in research and development and its expenditure, along with
increasing investment by government organizations, especially in the developed
countries in the North America and Europe, are expected to create lucrative
opportunities for the market growth in coming years. Besides, increasing
attention on biomarker discovery and the growing application of toxic genomics
are further expected to support the market growth. Similarly, the growing application
of RNA sequencing along with the development of new transcriptomics products
further enhanced the demand for the development of novel drugs which will boost
the market growth during the forecast period. Also, increasing the number of
large key players across the globe will propel the growth of the
transcriptomics market during the forecast period.
However,
the lack of efficient data analysis tools is slowing down the growth of global
transcriptomics market in the forecast period. Similarly, increasing
technological advances create data complexity after analysis of transcripts
through sequencing platforms which will show negative results and may hamper
the transcriptomics market growth during the forecast period. Also, the lack of
skilled professionals for handling the transcriptomics in emerging countries
can further restrict the growth of global transcriptomics market. Similarly,
high capital investment requirements and data management issues may hamper the
growth of the market during the forecast period.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Transcriptomics Market"
The global transcriptomics market is segmented into
component, technology, application, end user, regional distribution and
company.
Based on Technology, Next Generation Sequencing is
exhibiting the fastest growth rate. NGS has revolutionized transcriptomics by
enabling high-throughput, highly accurate, and comprehensive RNA sequencing
(RNA-seq) to capture full transcriptome profiles, including gene expression
levels, alternative splicing, and novel transcript discovery. The rapid growth
of NGS in transcriptomics is driven by several key factors. First, the cost of
sequencing has dramatically declined over the past decade. According to the
National Human Genome Research Institute (NHGRI), the cost of sequencing a
human genome dropped from nearly $100 million in 2001 to under $1,000 by 2022,
making NGS more accessible for both academic and commercial applications. This
cost reduction has similarly benefitted RNA sequencing, allowing researchers
and clinicians to deploy transcriptomic tools more routinely and on a scale.
Based on the Region, the Asia Pacific region is witnessing
the fastest growth in the global transcriptomics market, driven by significant
investments in genomics research, increasing prevalence of chronic diseases,
and rapidly expanding biotechnology infrastructure across emerging economies
such as China, India, South Korea, and Japan. This growth is further bolstered
by government-led genomic initiatives and policies aimed at accelerating
biomedical innovation and precision medicine. In China, the government has
prioritized genomics as a critical component of its national strategy for
health innovation. The 13th Five-Year Plan for Economic and Social Development
(2016–2020) and follow-up programs have heavily invested in life sciences, with
institutions like BGI Genomics and China National GeneBank (CNGB) playing key
roles in large-scale transcriptomic studies. China’s Ministry of Science and
Technology has also funded programs for developing cutting-edge omics
technologies, making it a global hub for transcriptomic R&D.
Major
companies operating in the Global Transcriptomics Market are:
- Agilent
Technologies, Inc.
- ANGLE
plc.
- Bio-Rad
Laboratories, Inc.
- Becton,
Dickinson, and Company
- Fluidigm
Corporation
- BioSypder,
Inc.
- Danaher
Corporation
- 10x
Genomics, Inc.
- Pacific
Biosciences of California, Inc.
- NanoString
Technologies, Inc.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the global transcriptomics market, due to the increasing demand
for different types of chronic diseases such as obesity, hepatitis B, and
cancer among the population across the region. Similarly, the growth in demand
for faster testing for genetic testing and research will enhance the demand for
transcriptomics which will boost the market during the forecast period.
Furthermore, increasing number of key players in the market along with growing
development in the healthcare sector, complemented by increasing investment by
major key players to produce novel drugs, are further contributing to the
demand for transcriptomics. Besides, increasing favorable government
reimbursement policies, growing demand for new transcriptomics, and growing
awareness about the usage and benefits of transcriptomics in the region, are
further expected to create lucrative opportunities for the market growth,” said
Mr. Karan Chechi, Research Director of TechSci Research, a research based
global management consulting firm.
“Transcriptomics Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Component (Instruments,
Consumables, Software & Services), By Technology (Next Generation
Sequencing, Polymerase Chain Reaction, Microarray, In-Situ Hybridization,
Others), By Application (Drug Discovery & Development, Cell Biology, Single
Cell Analysis, Gene Expression, Others), By End User (Biotechnology &
Pharmaceutical Companies, Academic & Research Institutions, Others), By Region and Competition,
2020-2030F”, has
evaluated the future growth potential of global transcriptomics market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global transcriptomics market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com